Top

Sleep and Breathing

Published in:

Open Access 01-03-2022 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Original Article

Endothelial dysfunction in obstructive sleep apnea patients

Authors: Michał Harańczyk, Małgorzata Konieczyńska, Wojciech Płazak

Published in: Sleep and Breathing | Issue 1/2022

Abstract

Purpose

Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for cardiovascular diseases. The aim of the study was to assess the influence of OSAS on endothelial dysfunction and thrombosis biomarkers and to evaluate the effect of treatment with continuous positive airway pressure (CPAP) on biomarker levels.

Methods

NT-proBNP, sICAM-1, endothelin-1, von Willebrand factor, D-dimers, and thrombin-antithrombin complex (TAT) were measured in 50 patients diagnosed with moderate-to-severe OSAS. All patients underwent transthoracic echocardiography, and 38 months after the inclusion, 16 CPAP users and 22 non-CPAP users were reassessed.

Results

Sleep-related indices of apnea-hypopnea index (AHI) and mean SpO₂ were associated with higher sICAM-1 levels (AHI < 30: 7.3 ± 4.7 vs. AHI ≥ 30: 19.5 ± 19.4 mg/ml, p = 0.04; SpO₂ ≥ 90%: 11.9 ± 9.3 vs. SpO₂ < 90%: 23.6 ± 25.8, p = 0.04). sICAM-1 levels were significantly higher in obese patients, particularly with BMI ≥ 40. Plasma levels of TAT were significantly correlated with the increased right ventricular size (right ventricular diameter ≤ 37 mm: 0.86 ± 0.70 vs. > 37 mm: 1.96 ± 1.20 ng/ml, p = 0.04). Endothelin-1 levels were higher in patients with decreased right ventricular function (right ventricle TDI-derived S′ ≥ 12 cm/s: 11.5 ± 10.9 vs. < 12 cm/s: 26.0 ± 13.2 pg/ml, p = 0.04). An increase in NT-proBNP was related to impaired parameters of the right ventricular contractile function. There were no correlations between long-term CPAP therapy and the levels of biomarkers.

Conclusion

Severe OSAS influences endothelial damage as manifested by an increase in sICAM-1 levels. Changes in right ventricular structure and function, observed mainly in patients with higher TAT and endothelin-1 levels, are also manifested by an increase in NT-proBNP levels. Long-term CPAP treatment does not seem to influence biomarkers in patients with moderate-to-severe OSAS, which may help to explain the lack of influence of CPAP on cardiovascular risk reduction.

Sarkar P, Mukherjee S, Chai-Coetzer CL, McEvoy RD (2018) The epidemiology of obstructive sleep apnoea and cardiovascular disease. J Thorac Dis 10:S4189–200. https://doi.org/10.21037/jtd.2018.12.56

Lavie L (2003) Obstructive sleep apnoea syndrome – an oxidative stress disorder. Sleep Med Rev 7:35–51. https://doi.org/10.1053/smrv.2002.0261CrossRefPubMed

Lattimore J o-DL, Celermajer DS, Wilcox I (2003) Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41:1429–37. https://doi.org/10.1016/S0735-1097(03)00184-0

Peter JH, Koehler U, Grote L, Podszus T (1995) Manifestations and consequences of obstructive sleep apnoea. Eur Respir J 8:1572–1583PubMed

Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum Inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 09:1003–1012. https://doi.org/10.5664/jcsm.3070CrossRef

De Luca CG, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D (2015) Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 11:27–36. https://doi.org/10.5664/jcsm.4358CrossRef

Liak C, Fitzpatrick M (2011) Coagulability in obstructive sleep apnea. Can Respir J 18:338–348. https://doi.org/10.1155/2011/924629CrossRefPubMedPubMedCentral

von Känel R, Natarajan L, Ancoli-Israel S, Mills PJ, Wolfson T, Gamst AC, Loredo JS, Dimsdale JE (2013) Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med 14:58–65. https://doi.org/10.1016/j.sleep.2012.07.009CrossRef

Robinson GV (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59:777–782. https://doi.org/10.1136/thx.2003.018739CrossRefPubMedPubMedCentral

10.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200. https://doi.org/10.1093/eurheartj/ehw128CrossRefPubMed

11.

Oremus M, Don-Wauchope A, McKelvie R, Santaguida PL, Hill S, Balion C, Booth R, Brown JA, Ali U, Bustamam A, Sohel N, Raina P (2014) BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev 19:471–505. https://doi.org/10.1007/s10741-014-9439-6CrossRefPubMed

12.

Hendricks S, Dykun I, Balcer B, Al-Rashid F, Luedike P, Totzeck M, Rassaf T, Mahabadi AA (2020) Higher BNP/NT-proBNP levels stratify prognosis in patients with coronary artery disease but without heart failure. Eur Heart J 41(ehaa946):1335. https://doi.org/10.1093/ehjci/ehaa946.1335CrossRef

13.

Dursunoglu N, Dursunoglu D, Özkurt S, Gür S, Özalp G, Evyapan F (2006) Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res 7:22. https://doi.org/10.1186/1465-9921-7-22CrossRefPubMedPubMedCentral

14.

Otto ME, Belohlavek M, Romero-Corral A, Gami AS, Gilman G, Svatikova A, Amin RS, Lopez-Jimenez F, Khandheria BK, Somers VK (2007) Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99:1298–1302. https://doi.org/10.1016/j.amjcard.2006.12.052CrossRefPubMed

15.

Vitarelli A, Terzano C, Saponara M, Gaudio C, Mangieri E, Capotosto L, Pergolini M, D’Orazio S, Continanza G, Cimino E (2015) Assessment of right ventricular function in obstructive sleep apnea syndrome and effects of continuous positive airway pressure therapy: a pilot study. Can J Cardiol 31:823–831. https://doi.org/10.1016/j.cjca.2015.01.029CrossRefPubMed

16.

Marrone O, Bonsignore MR (2002) Pulmonary haemodynamics in obstructive sleep apnoea. Sleep Med Rev 6:175–193. https://doi.org/10.1053/smrv.2001.0185CrossRefPubMed

17.

Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 373:82–93. https://doi.org/10.1016/S0140-6736(08)61622-0CrossRef

18.

Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD (2015) Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015: An American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 11:773–827. https://doi.org/10.5664/jcsm.4858CrossRefPubMedPubMedCentral

19.

Qaseem A, Dallas P, Owens DK, Starkey M, Holty J-EC, Shekelle P (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the american college of physicians. Ann Intern Med 161:210. https://doi.org/10.7326/M12-3187

20.

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 23:685–713. https://doi.org/10.1016/j.echo.2010.05.010CrossRefPubMed

21.

Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK (2004) Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol 94:529–532. https://doi.org/10.1016/j.amjcard.2004.05.010CrossRefPubMed

22.

Kohno T, Kimura T, Fukunaga K, Yamasawa W, Fujisawa T, Fukuoka R, Nakajima K, Kashimura S, Kunitomi A, Katsumata Y, Nishiyama T, Nishiyama N, Aizawa Y, Fukuda K, Takatsuki S (2018) Prevalence and clinical characteristics of obstructive- and central-dominant sleep apnea in candidates of catheter ablation for atrial fibrillation in Japan. Int J Cardiol 260:99–102. https://doi.org/10.1016/j.ijcard.2018.01.103CrossRefPubMed

23.

Kulkas A, Duce B, Leppänen T, Hukins C, Töyräs J (2017) Severity of desaturation events differs between hypopnea and obstructive apnea events and is modulated by their duration in obstructive sleep apnea. Sleep Breath 21:829–835. https://doi.org/10.1007/s11325-017-1513-6CrossRefPubMed

24.

Kaditis AG, Alexopoulos EI, Kalampouka E, Hatzi F, Karadonta I, Kyropoulos T, Kaditis DG, Gourgoulianis K, Syrogiannopoulos GA (2007) Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring. Sleep Breath 11:267–274. https://doi.org/10.1007/s11325-007-0117-yCrossRefPubMed

25.

Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562–567. https://doi.org/10.1016/S0002-9343(00)00580-5CrossRefPubMed

26.

Carratù P, Ventura VA, Maniscalco M, Dragonieri S, Berardi S, Ria R, Quaranta VN, Vacca A, Devito F, Ciccone MM, Phillips BA, Resta O (2016) Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea. Sleep Breath 20:613–619. https://doi.org/10.1007/s11325-015-1260-5CrossRefPubMed

27.

Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, Giancarlo De Mattia (1999) Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 34:568–73. https://doi.org/10.1161/01.HYP.34.4.568

28.

Rohde LEP, Hennekens CH, Ridker PM (1999) Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 19:1595–1599. https://doi.org/10.1161/01.ATV.19.7.1595CrossRefPubMed

29.

Pak VM, Keenan BT, Jackson N, Grandner MA, Maislin G, Teff K, Schwab RJ, Arnardottir ES, Júlíusson S, Benediktsdottir B, Gislason T, Pack AI (2015) Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity. Int J Obes 39:472–479. https://doi.org/10.1038/ijo.2014.123CrossRef

30.

Ursavaş A, Karadağ M, Rodoplu E, Yılmaztepe A, Oral HB, Gözü RO (2007) Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 74:525–532. https://doi.org/10.1159/000097770CrossRefPubMed

31.

Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by doppler echocardiography compared to right heart catheterization: analysis in a large patient population. JAHA 3. https://doi.org/10.1161/JAHA.114.001103

32.

Zamarrón C, Riveiro A, Gude F (2011) Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Aoms 6:1023–8. https://doi.org/10.5114/aoms.2011.26615

33.

von Känel R, Loredo JS, Ancoli-Israel S, Dimsdale JE (2006) Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath 10:139–146. https://doi.org/10.1007/s11325-006-0060-3CrossRef

34.

von Känel R, Le DT, Nelesen RA, Mills PJ, Ancoli-Israel S, Dimsdale JE (2001) The hypercoagulable state in sleep apnea is related to comorbid hypertension. J Hypertens 19:1445–1451. https://doi.org/10.1097/00004872-200108000-00013CrossRef

35.

Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019) Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment. J Clin Sleep Med 15:301–334. https://doi.org/10.5664/jcsm.7638CrossRefPubMedPubMedCentral

36.

McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, Du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi-Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375:919–931. https://doi.org/10.1056/NEJMoa1606599CrossRefPubMed

37.

da Silva PF, Zhang L (2019) Continuous positive airway pressure for adults with obstructive sleep apnea and cardiovascular disease: a meta-analysis of randomized trials. Sleep Med 54:28–34. https://doi.org/10.1016/j.sleep.2018.09.030CrossRef

38.

Çifçi N, Uyar M, Elbek O, Süyür H, Ekinci E (2010) Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath 14:241–244. https://doi.org/10.1007/s11325-009-0306-yCrossRefPubMed

39.

Tasci S, Manka R, Scholtyssek S, Lentini S, Troatz C, Stoffel-Wagner B, Lüderitz B (2006) NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol 95:23–30. https://doi.org/10.1007/s00392-006-0315-9CrossRefPubMed

40.

Zhang X-B, Yuan Y-T, Du Y-P, Jiang X-T, Zeng H-Q (2015) Efficacy of positive airway pressure on brain natriuretic peptide in patients with heart failure and sleep-disorder breathing: a meta-analysis of randomized controlled trials. Lung 193:255–260. https://doi.org/10.1007/s00408-015-9684-zCrossRefPubMed

41.

Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184. https://doi.org/10.1152/japplphysiol.00177.2002CrossRefPubMed

42.

Grimpen F, Kanne P, Schulz E, Hagenah G, Hasenfuβ G, Andreas S (2000) Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 15:320. https://doi.org/10.1034/j.1399-3003.2000.15b17.xCrossRefPubMed

43.

Diefenbach K, Kretschmer K, Bauer S, Malzahn U, Penzel T, Roots I, Fietze I (2009) Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apnea. Cardiology 112:62–68. https://doi.org/10.1159/000137702CrossRefPubMed

44.

Turnbull CD, Rossi VA, Santer P, Schwarz EI, Stradling JR, Petousi N, Kohler M (2017) Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: further evidence from three randomized control trials: cardiovascular markers in OSA. Respirology 22:793–799. https://doi.org/10.1111/resp.12946CrossRefPubMed

45.

Lin G, Chen Q, Huang J, Chen L, Lin T, Lin Q (2019) Effect of continuous positive airway pressure on endothelin-1 in patients with obstructive sleep apnea: a meta-analysis. Eur Arch Otorhinolaryngol 276:623–630. https://doi.org/10.1007/s00405-018-5225-8CrossRefPubMed

46.

Phillips CL, McEwen BJ, Morel-Kopp M-C, Yee BJ, Sullivan DR, Ward CM, Tofler GH, Grunstein RR (2012) Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 67:639–644. https://doi.org/10.1136/thoraxjnl-2011-200874CrossRefPubMed

47.

El Shayeb M, Topfer L-A, Stafinski T, Pawluk L, Menon D (2014) Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. Can Med Assoc J 186:E25-51. https://doi.org/10.1503/cmaj.130952CrossRef

Title: Endothelial dysfunction in obstructive sleep apnea patients
Authors: Michał Harańczyk
Małgorzata Konieczyńska
Wojciech Płazak
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Sleep Apnea
Biomarkers
Published in: Sleep and Breathing / Issue 1/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02382-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Is there any relation between arterial stiffness and insomnia? A challenging question

Eight-week high-intensity interval training is associated with improved sleep quality and cardiorespiratory fitness in patients with depressive disorders

Cannabinoids and Sleep—Molecular, Functional and Clinical Aspects(2021) editors Monti JM, Pandi-Peumal SR, Murillo-Rodriguez E pp. 181 ISBN: 9,783,030,616,632 Springer

The variability and burden of severe sleep apnea and the relationship with atrial fibrillation occurrence: analysis of pacemaker-detected sleep apnea

Investigation of the relationships between sleep behaviors and risk of healthspan termination: a prospective cohort study based on 323,373 UK-Biobank participants

Validation of snoring detection using a smartphone app

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage